Dr. Joshua Woolley

Clinical-stage natural psychedelics company Filament Health Corp. (OTCQB: FLHLF) announced it will start providing patients with doses of the first FDA-approved study directly administering psilocin and psilocybin derived from mushrooms, as opposed to manufactured synthetic...